Refine by
Drug Platform Articles & Analysis
203 news found
RTsafe is proud to announce that its core innovation, the PseudoPatient®, has received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA). This important regulatory milestone enables RTsafe to market and distribute PseudoPatient across the Kingdom of Saudi Arabia and represents a significant step forward in the ...
ByRTsafe
Ace Therapeutics, a biotechnology company pioneering novel central nervous system (CNS) delivery solutions, today announced the release of its BBBporter™ technology platform. This innovative platform is specifically designed to overcome the primary challenge in treating brain diseases: the blood-brain barrier (BBB). ...
Due to their unique specificity and high activity, enzymes demonstrate significant potential in therapeutic drug development. However, their broader application is hindered by several limitations, the most significant of which are poor stability, potential immunogenicity and systemic toxicity risks. Considerable attention has been drawn to the use of nanoparticles with ...
This co-culture system also simulates tumour heterogeneity and evolutionary processes, providing an ideal platform for investigating CAF-mediated drug resistance, immune suppression and barriers to efficient drug delivery. ...
In an era where technological advancements are constantly reshaping the landscape of the pharmaceutical industry, Protheragen-ING has emerged as a frontrunner with its cutting-edge AI-synthesizer for small molecule drug synthesis. This revolutionary platform is transforming traditional drug formulation processes by employing a unique combination ...
The platform developed by Protheragen-ING AI-Pharma is a revolutionary step forward in the identification and optimization of drug candidates. ...
Kelly Bugatti, BOC Sciences is set to host an informative webinar that will delve into the latest advancements in utilizing Peptide-Drug Conjugates (PDCs) for the targeted treatment of Pulmonary Fibrosi BOC Sciences has been organizing regular webinars in the fields of life sciences, drug discovery, and chemistry. ...
CD Formulation, a leader in biotechnological innovation, is advancing the field of targeted drug delivery with its customized metal-organic frameworks (MOFs) services. ...
With customized delivery strategies, precise drug modifications, and advanced platforms, CD Bioparticles can streamline scientific research and development. ...
This platform allows for the controlled release of drugs over an extended period, providing patients with a consistent and steady supply of medication. By optimizing the release profile of drugs, this platform can improve patient compliance and reduce the risk of side effects associated with fluctuating drug ...
This technique allows for targeted drug delivery and controlled release, protecting the drug from degradation and enhancing its stability. Furthermore, CD Formulation specializes in nanoparticle development services for drug delivery systems. Nanoparticles, with their unique properties, can facilitate targeted drug delivery, ...
However, as with any medical product, it is crucial to assess the safety and potential toxicity of these novel drug delivery platforms. This is where CD Formulation steps in, providing state-of-the-art in vitro cytotoxicity testing for microspheres and microneedles. CD Formulation, a leader in the field of pharmaceutical formulation development, has been at the ...
Customization for Personalized Medicine: Antibodies are tailored to individual patient profiles, enhancing the potential for personalized medicine and increasing treatment efficacy while minimizing side effects. 5. Integration with Protein Drug Design: CD ComputaBio's platform seamlessly integrates Antibody De Novo Design with Protein ...
CD Formulation, a reputable contract research organization (CRO) based in New York, has become a trusted partner for many pharmaceutical companies around the world seeking innovative drug formulation methods and solutions. Recently, CD Formulation further strengthened its role as a drug delivery expert by demonstrating its expertise in the development of ...
Targeting Drug Delivery The XDC bioconjugation platform also offers comprehensive targeting strategies that enable drugs to be delivered specifically to the desired site of action. ...
As part of its service portfolio, CD ComputaBio has launched the Computer Aided Drug Design (CADD) platform. This platform combines artificial intelligence and machine learning to streamline data processing, analysis, and model construction throughout the drug development process. Equipped with robust tools and algorithms, the ...
Meanwhile, the new services are expected to help pharmaceutical companies develop safe and effective drugs more quickly and efficiently, ultimately benefiting patients and improving outcomes. ...
With customized delivery strategies, precise design and transformation of drugs/drug-loaded cargos, and advanced technology platforms, CD Bioparticles now offers a series of mRNA Transfection Reagents for researchers to assist the transfection of lipid vectors for mRNA into target cells. ...
– a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader technologies. ...
The company plans to continue growing its team to power the expansion of Juvena’s drug discovery platform and advance the company’s biologics pipeline targeting chronic and age-related diseases. ...